Endocrine and Targeted Manipulation of Breast Cancer
Sixth Cambridge Conference - May 2007
This educational program was directed by Steven E. Come, MD, Beth Israel Deaconess Medical Center, Aman U. Buzdar, MD, MD Anderson Cancer Center, James N. Ingle, MD, Mayo Clinic, and Stephen RD Johnston, MD, PhD, FRCP, Royal Marsden Hospital.
Educational Objectives
1) Understand the recent data from the major trials of endocrine therapy in early breast cancer and implications for patient care: 2) understand the leading treatment strategies that combine endocrine therapy with chemotherapy and /or with biologic agents and implications for patient care; and 3) discuss recent data on breast cancer prevention and implications for patient care.
Educational Grant Support
The program was supported by educational grants provided by: AstraZeneca Pharmaceuticals, Pfizer, Inc. and Novartis Pharmaceuticals.
Sponsorship
CME sponsorship and program management are provided by InforMEDical.
The conference proceedings were published as a peer-reviewed educational supplement to Cancer, Vol 112, Issue S3, pp 673-678, Feb 1, 2008.
The CME activity based on the publication summary is effective December 2007 through December 2008.
Journal Website
(subscription may be required to access full journal supplement)
